ID21650A - PHARMACEUTICAL SUSPENSION CONSIST OF NEVIRAPIN HEMIHIDRAT - Google Patents

PHARMACEUTICAL SUSPENSION CONSIST OF NEVIRAPIN HEMIHIDRAT

Info

Publication number
ID21650A
ID21650A IDP981156A ID981156A ID21650A ID 21650 A ID21650 A ID 21650A ID P981156 A IDP981156 A ID P981156A ID 981156 A ID981156 A ID 981156A ID 21650 A ID21650 A ID 21650A
Authority
ID
Indonesia
Prior art keywords
hemihidrat
nevirapin
pharmaceutical suspension
suspension consist
consist
Prior art date
Application number
IDP981156A
Other languages
Indonesian (id)
Inventor
Karl Georg Dr Grozinger
Amale Ayoub Dr Hawi
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22006658&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID21650(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of ID21650A publication Critical patent/ID21650A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IDP981156A 1997-08-25 1998-08-24 PHARMACEUTICAL SUSPENSION CONSIST OF NEVIRAPIN HEMIHIDRAT ID21650A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5680397P 1997-08-25 1997-08-25

Publications (1)

Publication Number Publication Date
ID21650A true ID21650A (en) 1999-07-08

Family

ID=22006658

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP981156A ID21650A (en) 1997-08-25 1998-08-24 PHARMACEUTICAL SUSPENSION CONSIST OF NEVIRAPIN HEMIHIDRAT

Country Status (38)

Country Link
US (2) US6172059B1 (en)
EP (1) EP1019058B1 (en)
JP (1) JP3472261B2 (en)
KR (1) KR100426516B1 (en)
CN (1) CN1197578C (en)
AR (2) AR016869A1 (en)
AT (1) ATE326971T1 (en)
AU (1) AU742761B2 (en)
BG (1) BG64337B1 (en)
BR (1) BR9811994B1 (en)
CA (1) CA2301646C (en)
CL (1) CL2008003111A1 (en)
CO (1) CO4970742A1 (en)
CY (1) CY1105228T1 (en)
CZ (1) CZ290667B6 (en)
DE (1) DE69834655T2 (en)
DK (1) DK1019058T3 (en)
EG (1) EG24075A (en)
ES (1) ES2265666T3 (en)
HK (1) HK1027975A1 (en)
HR (1) HRP980461B1 (en)
HU (1) HU226063B1 (en)
ID (1) ID21650A (en)
IL (1) IL134185A (en)
MY (1) MY122272A (en)
NO (1) NO326226B1 (en)
NZ (1) NZ503414A (en)
PE (1) PE105799A1 (en)
PL (1) PL192361B1 (en)
PT (1) PT1019058E (en)
RS (1) RS49808B (en)
RU (1) RU2196584C2 (en)
SA (1) SA98190680B1 (en)
TR (1) TR200000490T2 (en)
TW (1) TW450812B (en)
UA (1) UA44370C2 (en)
WO (1) WO1999009990A1 (en)
ZA (1) ZA987623B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002092095A1 (en) * 2001-05-11 2002-11-21 Boehringer Ingelheim International Gmbh Use of nevirapine to treat or prevent lipid pathology in patients with hiv that is resistant to nevirapine
WO2003091290A1 (en) * 2002-04-23 2003-11-06 Boehringer Ingelheim Pharmaceuticals, Inc. Method for reduction of residual organic solvent in carbomer
ATE484284T1 (en) * 2005-08-31 2010-10-15 Cipla Ltd PHARMACEUTICAL COMBINATIONS WITH LAMIVUDINE, STAVUDINE AND NEVIRAPINE
WO2010006697A2 (en) * 2008-06-30 2010-01-21 Tibotec Pharmaceuticals Powders for reconstitution
DE112010004065T5 (en) * 2009-11-10 2012-10-25 North West University A method for increasing the solubility of a transcriptase inhibitor composition
CN102725293A (en) * 2009-12-17 2012-10-10 西北大学 A polymorph form of nevirapine and its preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366972A (en) 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
CA2030056C (en) * 1989-11-17 1995-10-17 Karl D. Hargrave 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines and their use in the prevention or treatment of hiv infection
US5571912A (en) * 1990-10-19 1996-11-05 Boehringer Ingelheim Pharmaceuticals, Inc. Method for the preparation of 5,11-dihydro-6h-dipyrido [3,2-b:2',3'-e][1,4]diazepines
DE4403311C1 (en) * 1994-02-03 1995-04-20 Boehringer Ingelheim Kg Process for the preparation of nevirapine (11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4-d iazepin]-6-one)

Also Published As

Publication number Publication date
ATE326971T1 (en) 2006-06-15
AU742761B2 (en) 2002-01-10
CZ290667B6 (en) 2002-09-11
BR9811994B1 (en) 2013-11-19
AR083451A2 (en) 2013-02-27
NZ503414A (en) 2002-11-26
AR016869A1 (en) 2001-08-01
PL192361B1 (en) 2006-10-31
TW450812B (en) 2001-08-21
UA44370C2 (en) 2002-02-15
MY122272A (en) 2006-04-29
HRP980461A2 (en) 1999-06-30
EP1019058B1 (en) 2006-05-24
YU9800A (en) 2001-12-26
EG24075A (en) 2008-05-11
HUP0003093A2 (en) 2001-08-28
CY1105228T1 (en) 2010-03-03
HRP980461B1 (en) 2002-08-31
US6172059B1 (en) 2001-01-09
KR20010023257A (en) 2001-03-26
PL338828A1 (en) 2000-11-20
RS49808B (en) 2008-08-07
NO20000906L (en) 2000-02-24
NO20000906D0 (en) 2000-02-24
CZ2000694A3 (en) 2000-09-13
DE69834655D1 (en) 2006-06-29
KR100426516B1 (en) 2004-04-13
CA2301646A1 (en) 1999-03-04
CA2301646C (en) 2008-11-18
BG64337B1 (en) 2004-10-29
HU226063B1 (en) 2008-04-28
CO4970742A1 (en) 2000-11-07
IL134185A0 (en) 2001-04-30
SA98190680B1 (en) 2006-04-04
RU2196584C2 (en) 2003-01-20
NO326226B1 (en) 2008-10-20
PT1019058E (en) 2006-08-31
CL2008003111A1 (en) 2009-09-11
PE105799A1 (en) 1999-11-16
ES2265666T3 (en) 2007-02-16
EP1019058A1 (en) 2000-07-19
WO1999009990A1 (en) 1999-03-04
US6255481B1 (en) 2001-07-03
JP2001513564A (en) 2001-09-04
HK1027975A1 (en) 2001-02-02
EP1019058A4 (en) 2004-11-10
DE69834655T2 (en) 2006-12-14
CN1268055A (en) 2000-09-27
ZA987623B (en) 2000-03-22
CN1197578C (en) 2005-04-20
DK1019058T3 (en) 2006-06-12
BG104133A (en) 2000-08-31
IL134185A (en) 2005-11-20
TR200000490T2 (en) 2000-08-21
JP3472261B2 (en) 2003-12-02
AU8777198A (en) 1999-03-16
BR9811994A (en) 2000-09-05

Similar Documents

Publication Publication Date Title
ID18500A (en) THE SUSPENSION OF THE UNRUPTED LIFESTYLE
CY2012029I2 (en) NEW FORM OF 5-OMEPRAZOLE
ID25629A (en) AMINA BISIKLIK (Fraction of P-961362)
ATE386439T1 (en) USES OF OIL BODY
DE59807805D1 (en) pressure atomizer
ID29994A (en) PHARMACEUTICAL COMPOSITION FOR AGAINST CCR5 CONSIST OF ANILIDA DECREASES
DE59801135D1 (en) Suspension strut bearing
DE122010000029I1 (en) SOLID MEDICAL CONSUMPTION CONTAINING BENZOFURANDERIVATE
DE69834090D1 (en) Head suspension unit
DE69818026D1 (en) AQUEOUS SUSPENSION FOR THE NASAL ADMINISTRATION OF LOTEPREDNOL
ID25535A (en) THE COMPOSITION OF THE BODY CONTAINS FROM THE SOFTWARE DRUGS THAT ARE TRAPPED OUT OF ITS DISTANCE
DE60008009D1 (en) SINGLE SUSPENSION
NO981166L (en) Preparation of ascorbyl monophosphates
ID22233A (en) TABLET HAS BEEN CONTAINED FROM PARASETAMOL
ATE289478T1 (en) ECTOPARASITICID AQUEOUS SUSPENSION FORMULATIONS OF SPINOSYNES
ID26137A (en) NEW PHARMACEUTICAL COMPOSITION OF TRIFOSPHATE URIDIN
ID24217A (en) CONTINUOUS EXTRACTION OF POLYAMIDES
ID24575A (en) CONTINUOUS EXTRACTION OF POLYAMIDES
ID29098A (en) FORMULATION OF SUSPENSION CONCENTRATES CONTAINING PIRIMETHANIL
DE69815165D1 (en) suspension system
DE69841436D1 (en) LAST SUSPENSION SYSTEM
ID21650A (en) PHARMACEUTICAL SUSPENSION CONSIST OF NEVIRAPIN HEMIHIDRAT
ID23086A (en) FORMULATION OF WATER SUSPENSION FROM RENATED PESTICIDES
DE59706515D1 (en) SINGLE SUSPENSION
ID23730A (en) CONTAINERS OF THE TRIANGLE CONSIST OF DIFFERENT PARTS